Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Initial Results from a Pilot Comparative Effectiveness Study of Three Methotrexate-Based Consensus Treatment Plans for Juvenile Localized Scleroderma.

Li SC, Torok KS, Rabinovich CE, Dedeoglu F, Becker ML, Ferguson PJ, Hong SD, Ibarra MF, Stewart K, Pope E, Higgins GC, Laxer RM, Mason T 2nd, Fuhlbrigge RC, Andrews T; CARRA Registry Investigators .

J Rheumatol. 2019 Oct 15. pii: jrheum.190311. doi: 10.3899/jrheum.190311. [Epub ahead of print]

PMID:
31615917
2.

Activation of human vascular endothelium in melanoma metastases induces ICAM-1 and E-selectin expression and results in increased infiltration with effector lymphocytes.

Weishaupt C, Steinert M, Brunner G, Schulze HJ, Fuhlbrigge RC, Goerge T, Loser K.

Exp Dermatol. 2019 Aug 24. doi: 10.1111/exd.14023. [Epub ahead of print]

PMID:
31444891
3.

Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.

Li SC, Fuhlbrigge RC, Laxer RM, Pope E, Ibarra MF, Stewart K, Mason T 2nd, Becker ML, Hong S, Dedeoglu F, Torok KS, Rabinovich CE, Ferguson PJ, Punaro M, Feldman BM, Andrews T, Higgins GC; CARRA Registry Investigators.

Pediatr Rheumatol Online J. 2019 Jul 15;17(1):43. doi: 10.1186/s12969-019-0350-5.

4.

T-cell trafficking plays an essential role in tumor immunity.

Aires DJ, Yoshida M, Richardson SK, Bai M, Liu L, Moreno R, Lazar AJF, Wick JA, Rich BE, Murphy G, Blumberg RS, Fuhlbrigge RC, Kupper TS.

Lab Invest. 2019 Jan;99(1):85-92. doi: 10.1038/s41374-018-0124-6. Epub 2018 Oct 23.

5.

The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases.

Ringold S, Nigrovic PA, Feldman BM, Tomlinson GA, von Scheven E, Wallace CA, Huber AM, Schanberg LE, Li SC, Weiss PF, Fuhlbrigge RC, Morgan EM, Kimura Y.

Arthritis Rheumatol. 2018 May;70(5):669-678. doi: 10.1002/art.40395. Epub 2018 Mar 31.

6.

Staged development of long-lived T-cell receptor αβ TH17 resident memory T-cell population to Candida albicans after skin infection.

Park CO, Fu X, Jiang X, Pan Y, Teague JE, Collins N, Tian T, O'Malley JT, Emerson RO, Kim JH, Jung Y, Watanabe R, Fuhlbrigge RC, Carbone FR, Gebhardt T, Clark RA, Lin CP, Kupper TS.

J Allergy Clin Immunol. 2018 Aug;142(2):647-662. doi: 10.1016/j.jaci.2017.09.042. Epub 2017 Nov 9.

7.

IL-1R Type 1-Deficient Mice Demonstrate an Impaired Host Immune Response against Cutaneous Vaccinia Virus Infection.

Tian T, Jin MQ, Dubin K, King SL, Hoetzenecker W, Murphy GF, Chen CA, Kupper TS, Fuhlbrigge RC.

J Immunol. 2017 Jun 1;198(11):4341-4351. doi: 10.4049/jimmunol.1500106. Epub 2017 May 3.

8.

Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome: Analysis of Patients From Two Geographic Areas.

Batu ED, Kara Eroğlu F, Tsoukas P, Hausmann JS, Bilginer Y, Kenna MA, Licameli GR, Fuhlbrigge RC, Özen S, Dedeoğlu F.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1859-1865. doi: 10.1002/acr.22901.

9.

Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis.

Henderson LA, Volpi S, Frugoni F, Janssen E, Kim S, Sundel RP, Dedeoglu F, Lo MS, Hazen MM, Beth Son M, Mathieu R, Zurakowski D, Yu N, Lebedeva T, Fuhlbrigge RC, Walter JE, Nee Lee Y, Nigrovic PA, Notarangelo LD.

Arthritis Rheumatol. 2016 Jul;68(7):1758-68. doi: 10.1002/art.39606.

10.

Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures.

Bohr AH, Fuhlbrigge RC, Pedersen FK, de Ferranti SD, Müller K.

Pediatr Rheumatol Online J. 2016 Jan 6;14(1):3. doi: 10.1186/s12969-015-0061-5. Review.

11.

CCR7 plays no appreciable role in trafficking of central memory CD4 T cells to lymph nodes.

Vander Lugt B, Tubo NJ, Nizza ST, Boes M, Malissen B, Fuhlbrigge RC, Kupper TS, Campbell JJ.

J Immunol. 2013 Sep 15;191(6):3119-27. doi: 10.4049/jimmunol.1200938. Epub 2013 Aug 9.

12.

Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cells.

Chang DK, Sui J, Geng S, Muvaffak A, Bai M, Fuhlbrigge RC, Lo A, Yammanuru A, Hubbard L, Sheehan J, Campbell JJ, Zhu Q, Kupper TS, Marasco WA.

Mol Cancer Ther. 2012 Nov;11(11):2451-61. doi: 10.1158/1535-7163.MCT-12-0278. Epub 2012 Aug 6.

13.

Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells.

Purwar R, Schlapbach C, Xiao S, Kang HS, Elyaman W, Jiang X, Jetten AM, Khoury SJ, Fuhlbrigge RC, Kuchroo VK, Clark RA, Kupper TS.

Nat Med. 2012 Aug;18(8):1248-53. doi: 10.1038/nm.2856. Epub 2012 Jul 8.

14.

Ly6G ligation blocks recruitment of neutrophils via a β2-integrin-dependent mechanism.

Wang JX, Bair AM, King SL, Shnayder R, Huang YF, Shieh CC, Soberman RJ, Fuhlbrigge RC, Nigrovic PA.

Blood. 2012 Aug 16;120(7):1489-98. doi: 10.1182/blood-2012-01-404046. Epub 2012 Jun 1.

15.

Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation.

Ercan A, Barnes MG, Hazen M, Tory H, Henderson L, Dedeoglu F, Fuhlbrigge RC, Grom A, Holm IA, Kellogg M, Kim S, Adamczyk B, Rudd PM, Son MB, Sundel RP, Foell D, Glass DN, Thompson SD, Nigrovic PA.

Arthritis Rheum. 2012 Sep;64(9):3025-33. doi: 10.1002/art.34507.

16.

Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.

Li SC, Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT, Rabinovich CE, Laxer RM, Higgins GC, Ferguson PJ, Lasky A, Baszis K, Becker M, Campillo S, Cartwright V, Cidon M, Inman CJ, Jerath R, O'Neil KM, Vora S, Zeft A, Wallace CA, Ilowite NT, Fuhlbrigge RC; Childhood Arthritis and Rheumatology Research Alliance (CARRA) Localized Scleroderma Workgroup.

Arthritis Care Res (Hoboken). 2012 Aug;64(8):1175-85. doi: 10.1002/acr.21687.

17.

Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity.

Jiang X, Clark RA, Liu L, Wagers AJ, Fuhlbrigge RC, Kupper TS.

Nature. 2012 Feb 29;483(7388):227-31. doi: 10.1038/nature10851.

18.

Disruption of TNF-α/TNFR1 function in resident skin cells impairs host immune response against cutaneous vaccinia virus infection.

Tian T, Dubin K, Jin Q, Qureshi A, King SL, Liu L, Jiang X, Murphy GF, Kupper TS, Fuhlbrigge RC.

J Invest Dermatol. 2012 May;132(5):1425-34. doi: 10.1038/jid.2011.489. Epub 2012 Feb 9.

19.

Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany.

Peiser M, Tralau T, Heidler J, Api AM, Arts JH, Basketter DA, English J, Diepgen TL, Fuhlbrigge RC, Gaspari AA, Johansen JD, Karlberg AT, Kimber I, Lepoittevin JP, Liebsch M, Maibach HI, Martin SF, Merk HF, Platzek T, Rustemeyer T, Schnuch A, Vandebriel RJ, White IR, Luch A.

Cell Mol Life Sci. 2012 Mar;69(5):763-81. doi: 10.1007/s00018-011-0846-8. Epub 2011 Oct 14. Review.

20.

Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells.

Merzaban JS, Burdick MM, Gadhoum SZ, Dagia NM, Chu JT, Fuhlbrigge RC, Sackstein R.

Blood. 2011 Aug 18;118(7):1774-83. doi: 10.1182/blood-2010-11-320705. Epub 2011 Jun 9.

21.

TGF-β suppresses β-catenin-dependent tolerogenic activation program in dendritic cells.

Vander Lugt B, Beck ZT, Fuhlbrigge RC, Hacohen N, Campbell JJ, Boes M.

PLoS One. 2011;6(5):e20099. doi: 10.1371/journal.pone.0020099. Epub 2011 May 20.

22.

The immune system, the skin, and childhood rheumatic disease.

Fuhlbrigge RC, Chaiban R.

Curr Rheumatol Rep. 2011 Apr;13(2):103-9. doi: 10.1007/s11926-010-0158-2. Review.

PMID:
21234730
23.

Restoration of peripheral blood T cell repertoire complexity during remission in advanced cutaneous T cell lymphoma.

Yamanaka K, Fuhlbrigge RC, Mizutani H, Kupper TS.

Arch Dermatol Res. 2010 Aug;302(6):453-9. doi: 10.1007/s00403-009-1023-x. Epub 2010 Jan 29.

24.

Update in paediatric vasculitis.

Ozen S, Fuhlbrigge RC.

Best Pract Res Clin Rheumatol. 2009 Oct;23(5):679-88. doi: 10.1016/j.berh.2009.07.004. Review.

PMID:
19853832
25.

Immunology and skin disease 2009: frontiers in cutaneous immunology.

Clark RA, Fuhlbrigge RC.

J Invest Dermatol. 2009 Aug;129(8):1849-51. doi: 10.1038/jid.2009.166. No abstract available.

26.

Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.

Kim S, El-Hallak M, Dedeoglu F, Zurakowski D, Fuhlbrigge RC, Sundel RP.

Arthritis Rheum. 2009 Jun;60(6):1825-1830. doi: 10.1002/art.24571.

27.

Maintenance of peripheral tolerance through controlled tissue homing of antigen-specific T cells in K14-mOVA mice.

Bianchi T, Pincus LB, Wurbel MA, Rich BE, Kupper TS, Fuhlbrigge RC, Boes M.

J Immunol. 2009 Apr 15;182(8):4665-74. doi: 10.4049/jimmunol.0803628.

28.

Overexpression of IL-1alpha in skin differentially modulates the immune response to scarification with vaccinia virus.

Tian T, Liu L, Freyschmidt EJ, Murphy GF, Kupper TS, Fuhlbrigge RC.

J Invest Dermatol. 2009 Jan;129(1):70-8. doi: 10.1038/jid.2008.191. Epub 2008 Jul 10.

29.

Research priorities in pediatric rheumatology: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) consensus.

Ota S, Cron RQ, Schanberg LE, O'Neil K, Mellins ED, Fuhlbrigge RC, Feldman BM.

Pediatr Rheumatol Online J. 2008 Apr 1;6:5. doi: 10.1186/1546-0096-6-5.

30.

Identification of cells initiating human melanomas.

Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, Fuhlbrigge RC, Kupper TS, Sayegh MH, Frank MH.

Nature. 2008 Jan 17;451(7176):345-9. doi: 10.1038/nature06489.

31.

Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression.

Yamanaka K, Dimitroff CJ, Fuhlbrigge RC, Kakeda M, Kurokawa I, Mizutani H, Kupper TS.

J Allergy Clin Immunol. 2008 Jan;121(1):148-157.e3. Epub 2007 Oct 1.

32.

Meeting report of immunology and skin disease: new perspectives.

Clark RA, Fuhlbrigge RC.

J Invest Dermatol. 2007 Aug;127(8):1838-41. No abstract available.

33.

Adhesion molecules in cutaneous immunity.

Fuhlbrigge RC, Weishaupt C.

Semin Immunopathol. 2007 Apr;29(1):45-57. Review.

PMID:
17621953
34.

T-cell distribution and adhesion receptor expression in metastatic melanoma.

Weishaupt C, Munoz KN, Buzney E, Kupper TS, Fuhlbrigge RC.

Clin Cancer Res. 2007 May 1;13(9):2549-56.

35.

The 130-kDa glycoform of CD43 functions as an E-selectin ligand for activated Th1 cells in vitro and in delayed-type hypersensitivity reactions in vivo.

Alcaide P, King SL, Dimitroff CJ, Lim YC, Fuhlbrigge RC, Luscinskas FW.

J Invest Dermatol. 2007 Aug;127(8):1964-72. Epub 2007 Mar 29.

36.

Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.

El-Hallak M, Binstadt BA, Leichtner AM, Bennett CM, Neufeld EJ, Fuhlbrigge RC, Zurakowski D, Sundel RP.

J Pediatr. 2007 Apr;150(4):376-82.

PMID:
17382113
37.

The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors.

Hirahara K, Liu L, Clark RA, Yamanaka K, Fuhlbrigge RC, Kupper TS.

J Immunol. 2006 Oct 1;177(7):4488-94.

38.

Dynamic programming of CD8+ T cell trafficking after live viral immunization.

Liu L, Fuhlbrigge RC, Karibian K, Tian T, Kupper TS.

Immunity. 2006 Sep;25(3):511-20.

39.

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.

Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, Kim HJ, Brewer C, Zalewski C, Wiggs E, Hill S, Turner ML, Karp BI, Aksentijevich I, Pucino F, Penzak SR, Haverkamp MH, Stein L, Adams BS, Moore TL, Fuhlbrigge RC, Shaham B, Jarvis JN, O'Neil K, Vehe RK, Beitz LO, Gardner G, Hannan WP, Warren RW, Horn W, Cole JL, Paul SM, Hawkins PN, Pham TH, Snyder C, Wesley RA, Hoffmann SC, Holland SM, Butman JA, Kastner DL.

N Engl J Med. 2006 Aug 10;355(6):581-92.

40.

CD43 is a ligand for E-selectin on CLA+ human T cells.

Fuhlbrigge RC, King SL, Sackstein R, Kupper TS.

Blood. 2006 Feb 15;107(4):1421-6. Epub 2005 Nov 3.

41.

Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis.

Binstadt BA, Levine JC, Nigrovic PA, Gauvreau K, Dedeoglu F, Fuhlbrigge RC, Weindling SN, Newburger JW, Sundel RP.

Pediatrics. 2005 Jul;116(1):e89-93. Epub 2005 Jun 1.

PMID:
15930186
42.
43.

Immune surveillance in the skin: mechanisms and clinical consequences.

Kupper TS, Fuhlbrigge RC.

Nat Rev Immunol. 2004 Mar;4(3):211-22. Review. No abstract available.

PMID:
15039758
45.

Rituximab therapy for multisystem autoimmune diseases in pediatric patients.

Binstadt BA, Caldas AM, Turvey SE, Stone KD, Weinstein HJ, Jackson J, Fuhlbrigge RC, Sundel RP.

J Pediatr. 2003 Nov;143(5):598-604. Erratum in: J Pediatr. 2004 Apr;144(4):558.

PMID:
14615729
46.

Raynaud's phenomenon in children: a retrospective review of 123 patients.

Nigrovic PA, Fuhlbrigge RC, Sundel RP.

Pediatrics. 2003 Apr;111(4 Pt 1):715-21.

PMID:
12671102
47.

Increased CCR4 expression in cutaneous T cell lymphoma.

Ferenczi K, Fuhlbrigge RC, Pinkus J, Pinkus GS, Kupper TS.

J Invest Dermatol. 2002 Dec;119(6):1405-10.

48.

Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis.

Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP.

J Am Acad Dermatol. 2002 Oct;47(4):505-11.

PMID:
12271292
49.

Direct real-time observation of E- and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on Western blots.

Fuhlbrigge RC, King SL, Dimitroff CJ, Kupper TS, Sackstein R.

J Immunol. 2002 Jun 1;168(11):5645-51.

50.

Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1.

Pendl GG, Robert C, Steinert M, Thanos R, Eytner R, Borges E, Wild MK, Lowe JB, Fuhlbrigge RC, Kupper TS, Vestweber D, Grabbe S.

Blood. 2002 Feb 1;99(3):946-56.

PMID:
11806998

Supplemental Content

Loading ...
Support Center